Statistical analysis and Multi-way Analysis of Variance establish relationships between key performance metrics and proposed geometry descriptors.
Parallel factor (PARAFAC) is a subset of multi-way analysis and has initially been introduced as a data analysis tool in psychometrics and chemometrics.
All models apply a one-way sensitivity analysis; in addition, three reports also perform a multi-way analysis and two perform a probabilistic sensitivity analysis.
Experiments were conducted using three independents replicates, statistical analysis was undertaken using multi-way analysis of variance, and the averages were compared by Tukey range tests.
The focus will be on the generic principles of multi-way analysis using three-way data in order to gently introduce the new concepts.
A class of multivariate data analytical techniques called multi-way analysis encompass techniques that have been designed to handle and analyse such data structures directly.
Multi-way analysis of variance and regression trees were applied to establish correlations between HCN yield and catalyst composition (support and metal additives).
In signal processing and communication applications of multi-way analysis, data with PARALIND structure arise in many problems due to what is known as spatial multipath, and where identical signals appear with different angles and delays.
In the last years, multi-way analysis has become increasingly important because it has proved to be a valuable tool, e.g. in interpreting data provided by instrumental methods that describe the multivariate and complex reality of a given problem.
A multi-way analysis of variance is then used to examine potential interactions among factors affecting the EnKF experiments, achieving optimality of the RDAS with maximized performance of hydrologic predictions.
In the present paper, the benefits of a multilevel approach in multi-way analysis (nPLS-DA) will be described for the analysis of metabolomics data of a double blinded, randomized, parallel intervention trial with twenty slightly overweight men, whom received a diclofenac or placebo treatment for nine days.
